IMGN - イミュノジェン (ImmunoGen Inc.) イミュノジェン

 IMGNのチャート


 IMGNの企業情報

symbol IMGN
会社名 ImmunoGen Inc. (イミュノジェン)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 イミュノジェン(ImmunoGen Inc.)は抗体-薬物コンジュゲート(ADC)技術を使用して標的がん治療薬を開発する臨床段階のバイオテクノロジー会社である。同社の技術を用いたADCは、ADCがその標的に結合した後に腫瘍細胞を死滅させるペイロードとしてその抗癌剤の1つに結合した腫瘍細胞上に見出される標的に結合する抗体を含む。その製品候補には、Mirvetuximab soravtansine、IMGN779、IMGN632、及びColtuximab ravtansineが含まれる。同社のポートフォリオは、FORWARD Iと呼ばれるフェーズⅢ登録試験中の葉酸受容体アルファ(Fra)を標的とした初のADCであり、Mirvetuximab soravtansineによって導かれている。FORWARD II試験は、アバスチン(ベバシズマブ)、Keytruda(ペンブロリズマブ)およびカルボプラチンと組み合わせて、ミルベキシマブソラバタンシンを評価するコホートからなる。同社は、DM1およびDM4、並びにIGNと呼ばれるデオキシリボ核酸(DNA)アルキル化剤を含むチューブリン作用性メイタンシノイドペイロード剤を開発した。   イミュノジェンは、米国のバイオ医薬品会社。がんに対する標的治療剤の開発、製造、販売を行う。同社の抗体薬物複合体(ADC)技術は、同社の細胞死滅性化合物を特異的にがん細胞に到達させるため、がん細胞を標的とする抗体を用いている。また、それ自体抗がん活性を有する抗体も同社で開発する。本社は、マサチュ―セッツ州ウォルサム。   ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.
本社所在地 830 Winter Street Waltham MA 02451 USA
代表者氏名 Stephen C. McCluski Stephen C. McCluski
代表者役職名 Independent Chairman of the Board
電話番号 +1 781-895-0600
設立年月日 29646
市場名 NASDAQ National Market System
ipoyear 1989年
従業員数 293人
url www.immunogen.com
nasdaq_url https://www.nasdaq.com/symbol/imgn
adr_tso
EBITDA EBITDA(百万ドル) -105.55200
終値(lastsale) 8.2
時価総額(marketcap) 1221974848.6
時価総額 時価総額(百万ドル) 1107.228
売上高 売上高(百万ドル) 77.03000
企業価値(EV) 企業価値(EV)(百万ドル) 764.22700
当期純利益 当期純利益(百万ドル) -150.03700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ImmunoGen Inc. revenues decreased 57% to $29.1M. Net loss increased from $26.2M to $80.2M. Revenues reflect License and milestone fees decrease of 74% to $12.9M Research and development support decrease of 68% to $771K Clinical materials revenue decrease of 19% to $1M. Higher net loss reflects Preclinical and Clinical Testing increase of 50% to $46.9M (expense).

 IMGNのテクニカル分析


 IMGNのニュース

   ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference  2020/09/02 20:30:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
   Warner Music acquires Israeli start-up IMGN for just under $100m  2020/08/18 07:11:58 SiliconRepublic
Tel Aviv and New York-based IMGN will continue to act as its own entity, helping Warner to build and track content on social media.
   Warner Music : IMGN Media Acquired by Warner Music Group | MarketScreener  2020/08/14 18:03:02 MarketScreener
Today it was announced that digital media company IMGN Media has been acquired by Warner Music Group. Founded in 2015, and headquartered in New York and Tel Aviv, IMGN will continue to be run… | August 14, 2020
   ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  2020/08/03 20:30:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
   ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers  2020/07/31 16:03:47 News Alphastreet
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year. For the full year of 2020, revenues are expected to be between $60-65 million. Click here to read the full […]
   ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference  2020/09/02 20:30:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference
   Warner Music acquires Israeli start-up IMGN for just under $100m  2020/08/18 07:11:58 SiliconRepublic
Tel Aviv and New York-based IMGN will continue to act as its own entity, helping Warner to build and track content on social media.
   Warner Music : IMGN Media Acquired by Warner Music Group | MarketScreener  2020/08/14 18:03:02 MarketScreener
Today it was announced that digital media company IMGN Media has been acquired by Warner Music Group. Founded in 2015, and headquartered in New York and Tel Aviv, IMGN will continue to be run… | August 14, 2020
   ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  2020/08/03 20:30:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
   ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers  2020/07/31 16:03:47 News Alphastreet
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year. For the full year of 2020, revenues are expected to be between $60-65 million. Click here to read the full […]
   ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers  2020/07/31 16:03:47 News Alphastreet
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per share, compared to a loss of $43.4 million, or $0.29 per share, last year. For the full year of 2020, revenues are expected to be between $60-65 million. Click here to read the full […]
   ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results  2020/07/31 10:30:00 Business Wire
ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results
   ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference  2020/07/29 20:30:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference
   ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer  2020/07/20 11:00:00 Business Wire
ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer
   ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2020 Operating Results  2020/07/16 20:01:00 Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2020 Operating Results

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 イミュノジェン IMGN ImmunoGen Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)